TheEdgeResearch
Home / Stocks / EVRRF

Molecule Holdings Inc. (EVRRF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$626,130
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.44
52-Wk Range
0.0025-0.0025
CEO
David Reingold
Country
CA
Currency
USD

Molecule Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Lansdowne, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $626,130. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of -230.8%. Its beta of -0.44 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.11
Price / Sales
0.25
Price / Book
-0.13
EV / EBITDA
-1.45
Gross margin
-54.6%
Operating margin
-198.9%
Net margin
-230.8%
Return on equity
Debt / equity
-1.41
Current ratio
0.17
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
13
IPO date
2020-09-22
Headquarters
Lansdowne, ON, CA
About Molecule Holdings Inc.

Molecule Holdings Inc. specializes in the Canadian production and contract packaging of cannabis-infused drinks. The company markets its range of beverages under brand names such as PHRESH, embody, and CANAJO. Its operational base is located in Lansdowne, Canada.

Comparable companies

Molecule Holdings Inc. is most often compared with the following Healthcare names:

AVCNFCAAOFCHOOFCRVWCWBHFGBLPISCNFLUFFFMEDIFRAPH
More research on EVRRF
EVRRF technical analysis EVRRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →